Search Clinical Trials

Clinical Trials Search Results

The results of your search are listed below. To view the details of a trial or study, click on the see details >> link. Or start a new search.

Searched for: melanoma

6 results total

Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma

See details >>

Principal Investigator: Cassian Yee, MD

Study Number: 2140.00

Phase I/II Study To Evaluate The Safety of Cellular Adoptive Immunotherapy Using Autologous CD4+ and CD8+ Antigen-Specific T Cell Clones for Patients with Metastatic Melanoma

See details >>

Principal Investigator: Cassian Yee, MD

Study Number: 2179.00

Phase I/II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ NY-ESO-1-Specific T Cell Clones and anti-CTLA4 for Patients With Metastatic Melanoma

See details >>

Principal Investigator: Aude Chapuis, MD

Study Number: 2225.00

Phase I/II Study To Evaluate The Safety Of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following CD25 Lymphodepletion For Patients With Metastatic Melanoma

See details >>

Principal Investigator: Sylvia Lee, MD

Study Number: 2271.00

A Phase III Randomized Study of Four Weeks of High-Dose IFN-alpha2b in Stage T3-T4 or N1 (Microscopic) Melanoma

See details >>

Principal Investigator: Frederick Appelbaum, MD

Study Number: CTSU E1697

A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMage-A3 + AS15 ASCI as Adjuvant Therapy in Patients with MAGE-A3 Positive Resected Stage III Melanoma

See details >>

Principal Investigator: John Thompson, MD

Study Number: 20081101

Search Options

Select a disease from the list below:

Limit results to studies enrolling:
Both Adults & Pediatrics Adults Pediatrics

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.